Align Technology, Inc. Stock

Equities

ALGN

US0162551016

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-06-07 pm EDT 5-day change 1st Jan Change
255.5 USD -0.75% Intraday chart for Align Technology, Inc. -0.65% -6.74%
Sales 2024 * 4.12B Sales 2025 * 4.52B Capitalization 19.24B
Net income 2024 * 534M Net income 2025 * 648M EV / Sales 2024 * 4.38 x
Net cash position 2024 * 1.2B Net cash position 2025 * 1.51B EV / Sales 2025 * 3.93 x
P/E ratio 2024 *
36.1 x
P/E ratio 2025 *
29.8 x
Employees 21,670
Yield 2024 *
-
Yield 2025 *
-
Free-Float 93.46%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.75%
1 week-0.65%
Current month-0.65%
1 month-10.81%
3 months-17.78%
6 months+17.97%
Current year-6.74%
More quotes
1 week
246.34
Extreme 246.335
260.00
1 month
246.34
Extreme 246.335
283.00
Current year
246.34
Extreme 246.335
335.40
1 year
176.34
Extreme 176.34
413.20
3 years
172.05
Extreme 172.05
737.45
5 years
127.88
Extreme 127.88
737.45
10 years
43.27
Extreme 43.27
737.45
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 15-05-31
Director of Finance/CFO 57 16-11-09
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 72 06-01-31
Chief Executive Officer 66 15-05-31
Director/Board Member 58 Dec. 04
More insiders
Date Price Change Volume
24-06-07 255.5 -0.75% 785,675
24-06-06 257.5 +0.57% 1,110,542
24-06-05 256 +2.85% 985,780
24-06-04 248.9 -2.21% 893,860
24-06-03 254.5 -1.04% 798,754

Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT

More quotes
Align Technology, Inc. specializes in the design, manufacturing and marketing of dental and medical devices. Net sales break down by family of products as follows: - clear aligners (82.8%): sold under the brand name Invisalign; - intra-oral scanners (17.2%): iTero. The group also offers scanner services. Net sales are distributed geographically as follows: the United States (43.1%), Switzerland (30.3%), and other (26.6%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
255.5 USD
Average target price
341.6 USD
Spread / Average Target
+33.69%
Consensus